CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Change in Receivables (2014 - 2026)

CNBX Pharmaceuticals' (CNBX) quarterly Change in Receivables came in at $563.0 in Q2 2026, up 3618.75% YoY from $15.14 in Q2 2025, and up 178.85% on a QoQ basis from -$714.0 in Q1 2026.

CNBX Pharmaceuticals Inc. (CNBX) Change in Receivables (2014 - 2026) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 6 years of Change in Receivables data on file, last reported at $563.0 in Q2 2026.

  • Quarterly Change in Receivables rose 3618.75% year-over-year to $563.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$1659.0 (changed 0.36% YoY) and the FY2025 annual result came in at -$1641.0, up 98.17% from the prior year.
  • Change in Receivables climbed to $563.0 in Q2 2026, from -$714.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $563.0 in Q2 2026 to a low of -$1653.0 in Q3 2024.
  • A 3-year average of -$473.14 and a median of -$16.0 in 2025 frame the typical range for Change in Receivables.
  • The widest YoY moves for Change in Receivables: up 3618.75% in 2026, down 4562.5% in 2026.
  • Tracing CNBX's Change in Receivables over 3 years: stood at -$1653.0 in 2024, then jumped by 108.05% to $133.0 in 2025, then jumped by 323.31% to $563.0 in 2026.
  • The last three Change in Receivables figures came in at $563.0 (Q2 2026), -$714.0 (Q1 2026), and $133.0 (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
May 31, 2026 563.00
May 31, 2026 563.00
Feb 28, 2026 -714.00
Feb 28, 2026 -714.00
Nov 30, 2025 133.00
Nov 30, 2025 133.00
Aug 31, 2025 -1,641.00
Aug 31, 2025 -1,641.00
May 31, 2025 -16.00
May 31, 2025 -16.00
Feb 28, 2025 16.00
Feb 28, 2025 16.00
Aug 31, 2024 -1,653.00
Aug 31, 2024 -1,653.00
May 31, 2016 -2,466.00
May 31, 2016 -2,466.00
Feb 29, 2016 -5,774.00
Feb 29, 2016 -5,774.00
Nov 30, 2015 10,013.00
Nov 30, 2015 10,013.00